| Ultrasound-mediated blood–brain barrier disruption for drug delivery: a systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds Pharmaceutics 14 (4), 833, 2022 | 41 | 2022 |
| Harnessing ultrasound for targeting drug delivery to the brain and breaching the blood–brain tumour barrier A Barzegar-Fallah, K Gandhi, SB Rizwan, TL Slatter, JNJ Reynolds Pharmaceutics 14 (10), 2231, 2022 | 10 | 2022 |
| Harnessing focused ultrasound for use in novel drug delivery strategies for neurological disorders K Gandhi University of Otago, 2023 | | 2023 |
| Gandhi et al. Ultrasound-Mediated Blood-Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and … K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds PHARMACEUTICS 15 (1), 2023 | | 2023 |
| Correction: Gandhi et al. Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical … K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds Pharmaceutics 15 (1), 5, 2022 | | 2022 |
| A focused ultrasound-mediated drug delivery system for Parkinson’s Disease. K Gandhi, J Gray, JNJ Reynolds Otago Medical School Research Society, 2022 | | 2022 |
| Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier. Pharmaceutics 2022, 14, 2231 A Barzegar-Fallah, K Gandhi, SB Rizwan, TL Slatter, JNJ Reynolds s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
